No CrossRef data available.
Article contents
Acatisia nocturna de comienzo diferido debido a risperidona y levomepromacina: un informe clínico
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Informe ClÍnico
- Information
- Copyright
- Copyright © European Psychiatric Association 2003
References
Bibliografía
1Sachdev, P. The development of the concept of akathisia: a historical overview. Schizophr Res 1995;l6(1):33–45.CrossRefGoogle Scholar
2Walters, AS, Hening, W. Rubinstein, M, et al. A clinical and polysomnography comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome. Sleep 1991;14(4):339-45.Google Scholar
3Lai, S, Nair, NP. Is levomepromazine a useful drug in treatmentresistant schizophrenia? Acta Psychiatr Scand 1992;85(3):243-5.Google Scholar
4Blaisdell, GD. Akathisia: a comprehensive review and treatment summary. Pharmacopsychiatry 1994;27(4):139-46.CrossRefGoogle ScholarPubMed
5Miller, CH, Mohr, F, Umbricht, D, et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 1998;59(2):69–75.CrossRefGoogle ScholarPubMed
6Meltzer, HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21 (2 Suppl):106S-15S.CrossRefGoogle ScholarPubMed
7Lai, S, Nair, NP, Cecyre, D, et al. Levomepromazine receptor binding profile in human brain-implications for treatmentresistant schizophrenia. Acta Psychiatr Scand 1993;87(6):380-3.Google Scholar